×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Breast Cancer 2022
Final Programme PDF
Advanced Search
03.05.2022
04.05.2022
05.05.2022
Controversy session
ESMO Guidelines session
Educational session
Industry Satellite Symposium
Keynote lecture
Mini Oral session
Multidisciplinary Tumour Board
Poster Display session
Proffered Paper session
Special Symposium
Special session
Young Oncologists session
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
Berlin Hall
14:10(30m)
Keynote lecture: How shall our knowledge of cancer evolution transform breast oncology?
16:45(1h 30m)
Proffered Paper session 2
Frankfurt Hall
14:45(1h 30m)
Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC)
18:30(1h)
Daiichi Sankyo / AstraZeneca - A new horizon for HER2 expressing breast cancer
08:45(1h 30m)
Genetic testing and implications in early breast cancer (eBC) patients
10:45(1h 30m)
Major advances for breast cancer survivorship
13:00(1h)
Young Oncologists session 3
Hamburg Hall
09:00(1h)
Mini Oral session 2
18:30(1h)
Novartis - HR+/HER2− Breast Cancer: How the Latest Data Help Inform Treatment Decisions
10:45(1h 30m)
Oligometastatic diseases (OMD)
13:00(1h)
Pfizer Oncology - Broadening horizons in HER2- advanced breast cancer
14:45(1h 30m)
Tailoring treatment for early HER2 breast cancer
Munich Hall
14:45(1h 30m)
Antibody drug conjugates (ADCs) to treat breast cancer
09:00(1h)
Can we decrease chemotherapy in LN+ premenopausal women based on genomic tests?
18:30(1h)
MSD - Advancements in immune-oncology for triple negative breast cancer
13:00(1h)
Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice
10:45(1h 30m)
Treatment strategies for HER2+ metastatic breast cancer (mBC)
Cologne Hall
10:45(45m)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
14:45(1h 30m)
EONS - Supportive care issues in breast cancer
08:45(1h 30m)
EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence?
13:00(1h)
Pierre Fabre - What about HER journey? Let’s focus on HER2+ early breast cancer
Exhibition area
12:15(45m)
Poster Display session
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events